Together we are beating cancer

Donate now

Thyroid cancer

Showing 7 out of 7 results
Loren (left) and Dinny (right), who both lost their voices during their cancer treatment

Dinny and Loren had different types of cancer, and in both cases the disease took away their voices. Until, of course, they found a way to break the silence. Dinny and Loren had different types of cancer, and in both cases the disease took away their voices. Until, of course, they found a way to break the silence.

by Paula Young, Jane Redman | Personal stories | 2 December 2022

2 December 2022

3D visualisation of thyroid cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer. The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer.

by Harry Jenkins | News | 1 October 2021

1 October 2021

Cancer Research UK logo

The number of people diagnosed with thyroid cancer in England has doubled since the early 1990s, according to a new report published by the National Cancer Intelligence Network (NCIN) today. The number of people diagnosed with thyroid cancer in England has doubled since the early 1990s, according to a new report published by the National Cancer Intelligence Network (NCIN) today.

by The National Cancer Intelligent Network | News | 14 December 2012

14 December 2012

Cancer Research UK logo

The results of a large Cancer Research UK trial have set a new gold standard for treating thyroid cancer, reducing radiation doses to just one third of the current level, according to research in The New England Journal of Medicine. The results of a large Cancer Research UK trial have set a new gold standard for treating thyroid cancer, reducing radiation doses to just one third of the current level, according to research in The New England Journal of Medicine.

by Cancer Research UK | News | 2 May 2012

2 May 2012

Cancer Research UK logo

Courageous cancer Survivor Findlay Young is half way through his mission to run 24 half marathons in 24 consecutive days in 24 different locations in 12 countries and six continents around the world for Cancer Research UK. Courageous cancer Survivor Findlay Young is half way through his mission to run 24 half marathons in 24 consecutive days in 24 different locations in 12 countries and six continents around the world for Cancer Research UK.

by Cancer Research UK | News | 20 September 2006

20 September 2006

Cancer Research UK logo

A courageous cancer survivor jogged alone across the Tyne Bridge at 6.00am on Thursday, September 7th to highlight the start of his fundraising mission to run 24 half marathons in 24 consecutive days, ending with the BUPA Great North Run. Findlay Young, 32, aims to raise Ј100,000 for Cancer Research UK after surviving thyroid cancer twice in two years. A courageous cancer survivor jogged alone across the Tyne Bridge at 6.00am on Thursday, September 7th to highlight the start of his fundraising mission to run 24 half marathons in 24 consecutive days, ending with the BUPA Great North Run. Findlay Young, 32, aims to raise Ј100,000 for Cancer Research UK after surviving thyroid cancer twice in two years.

by Cancer Research UK | News | 7 September 2006

7 September 2006